In the perioperative period, when is levodopa/carbidopa typically stopped?

In the perioperative period, when is levodopa/carbidopa typically stopped?

• A. Patients with hypertension
• B. Patients showing rigidity
• C. Patients with anxiety
• D. Patients with bradycardia

Answer: (B)

In the perioperative period, levodopa/carbidopa is typically stopped for patients showing rigidity. This is because rigidity can indicate an exacerbation of Parkinson's disease symptoms, and administering levodopa/carbidopa helps manage these symptoms. However, during surgery, particularly if the patient is undergoing procedures that may involve significant anesthesia or risk for complications related to muscle stiffness and rigidity, the medication is often paused. This is primarily due to the potential for interactions with anesthetic agents and the risk of improved muscle function leading to complications during surgery. In addition, the perioperative setting often necessitates close monitoring of neurological status, and managing Parkinson's symptoms becomes even more critical in this context. Therefore, stopping the medication in patients exhibiting rigidity helps to ensure a more controlled surgical environment and reduces the risk of complications associated with the medication's influence on motor function. In contrast, the other patient conditions listed may not warrant stopping the medication as there are alternative management strategies available, particularly since the main focus during surgery is often on neurological stability and managing movement disorders effectively.

In the perioperative period, levodopa/carbidopa is typically stopped for patients showing rigidity. This is because rigidity can indicate an exacerbation of Parkinson's disease symptoms, and administering levodopa/carbidopa helps manage these symptoms. However, during surgery, particularly if the patient is undergoing procedures that may involve significant anesthesia or risk for complications related to muscle stiffness and rigidity, the medication is often paused.

This is primarily due to the potential for interactions with anesthetic agents and the risk of improved muscle function leading to complications during surgery. In addition, the perioperative setting often necessitates close monitoring of neurological status, and managing Parkinson's symptoms becomes even more critical in this context. Therefore, stopping the medication in patients exhibiting rigidity helps to ensure a more controlled surgical environment and reduces the risk of complications associated with the medication's influence on motor function.

In contrast, the other patient conditions listed may not warrant stopping the medication as there are alternative management strategies available, particularly since the main focus during surgery is often on neurological stability and managing movement disorders effectively.